الولايات المتحدة · منصات وبيانات · Stocktwits

CADL Stock Tumbles 38% After-Hours As Candel Pushes Prostate Cancer FDA Application Timeline To Mid-2027

نشره Stocktwits · الولايات المتحدة منذ 14 س

ملخص مفصل

Candel said it is in continuing dialogue with the FDA regarding the Biologics License Application (BLA) submission for aglatimagene in intermediate- to high-risk localized…

اقرأ المقال كاملًا على Stocktwits سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (stocktwits.com)

يستحق القراءة أيضًا

Seeking Alpha

Recruit Holdings GAAP EPS of ¥159.54, revenue of ¥1.09T

MarketBeat

Kodiak Sciences (NASDAQ:KOD) Issues Earnings Results, Beats Estimates By $0.01 EPS

CNBC

How the Jensen Huang affair changes the outlook for U.S.-China relations

Investing.com

Matador Resources chairman and CEO buys $123,225 in stock

Benzinga

DeSantis Asks How Congress Members With 'No Investment Acumen' Outperform Warren Buffett — 'Oh You Just Happened to Buy Something…Then It Goes Up 150%'

MarketWatch